A long-term open-label safety and effectiveness trial of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder

Robert L. Findling, Andrew J. Cutler, Keith Saylor, Maria Gasior, Mohamed Hamdani, M. Celeste Ferreira-Cornwell, Ann C. Childress

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'A long-term open-label safety and effectiveness trial of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder'. Together they form a unique fingerprint.

Medicine & Life Sciences